Minneapolis-based Medtronic is spending $31 million to expand its European headquarters and production facilities in the Swiss state of Vaud. Medtronic supplies equipment for treating cardiac, vascular, neurologic, and spinal conditions.The project
Minneapolis-based Medtronic is spending $31 million to expand its European headquarters and production facilities in the Swiss state of Vaud. Medtronic supplies equipment for treating cardiac, vascular, neurologic, and spinal conditions.
The project brings Medtronics total investment in its Swiss facilities to $67 million. The expansion will add 200 new jobs, double Medtronics production capacity, provide a training center, and add room for administrative personnel, said Barry Wilson, Medtronics president of Europe, Africa, and the Middle East.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.